title: Adenovirus-mediated down-regulation of X-linked inhibitor of apoptosis protein inhibits colon cancer.
abstract: Our previous studies and those of others have indicated that X-linked inhibitor of apoptosis protein (XIAP) holds promise as a target gene in colon cancer gene therapy. In this study, we constructed an adenoviral vector to deliver small hairpin RNA (shRNA) against XIAP (XIAP-shRNA) into colon cancer cells and tested its therapeutic efficacy in vitro and in vivo. We first confirmed an overexpression of XIAP in colon cancer cells and human cancer tissues. We then designed XIAP-small interfering RNA (siRNA) and confirmed the knockdown effect of these siRNAs in colon cancer cells. The sequences of the effective siRNAs were converted into shRNA and then packed into replication-deficient adenoviral vectors using BLOCK-iT Adenoviral RNAi Expression System to generate Adv-XIAP-shRNA. Infection of HT29 and HCT116 cells with Adv-XIAP-shRNA led to enhanced caspase-3 activity, which was associated with increased apoptosis and reduced cell proliferation. The therapeutic effect of Adv-XIAP-shRNA was then tested in xenograft tumors in nude mice. We showed that treatment of the xenograft tumors derived from HCT116 cells with Adv-XIAP-shRNA resulted in a retardation of tumor growth, which was associated with enhanced apoptosis, increased caspase-3 activity, and reduced expression of proliferating cell nuclear antigen in the tumor tissues. Treatment of xenograft tumors with Adv-XIAP-shRNA did not affect the expressions of inflammatory cytokines in tumor-bearing mice. Thus, Adv-XIAP-shRNA-mediated down-regulation of XIAP exerts a therapeutic effect in colon cancer by promoting apoptosis and inhibiting proliferation of colon cancer cells, and the antitumor effect of Adv-XIAP-shRNA was unlikely to be related to virus-induced immune response.
authors.affiliation: Department of Gastroenterology, PekingUniversity First Hospital, Beijing, China.
authors.forename: Yun
authors.initials: Y
authors.lastname: Dai
authors.forename: Liang
authors.initials: L
authors.lastname: Qiao
authors.forename: Kwok Wah
authors.initials: KW
authors.lastname: Chan
authors.forename: Mo
authors.initials: M
authors.lastname: Yang
authors.forename: Jieyu
authors.initials: J
authors.lastname: Ye
authors.forename: Rongxin
authors.initials: R
authors.lastname: Zhang
authors.forename: Juan
authors.initials: J
authors.lastname: Ma
authors.forename: Bing
authors.initials: B
authors.lastname: Zou
authors.forename: Colin S C
authors.initials: CS
authors.lastname: Lam
authors.forename: Jide
authors.initials: J
authors.lastname: Wang
authors.forename: Roberta
authors.initials: R
authors.lastname: Pang
authors.forename: Victoria P Y
authors.initials: VP
authors.lastname: Tan
authors.forename: H Y
authors.initials: HY
authors.lastname: Lan
authors.forename: Benjamin C Y
authors.initials: BC
authors.lastname: Wong
mesh_terms: D000256:Adenoviridae / Q000502:physiology*; D000818:Animals; D017209:Apoptosis; D001483:Base Sequence; D015153:Blotting, Western; D002453:Cell Cycle; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D003110:Colonic Neoplasms / Q000517:prevention & control*; D017931:DNA Primers; D015536:Down-Regulation; D055785:Gene Knockdown Techniques; D006801:Humans; D007150:Immunohistochemistry; D051379:Mice; D008819:Mice, Nude; D012333:RNA, Messenger / Q000235:genetics; D051636:X-Linked Inhibitor of Apoptosis Protein / Q000235:genetics / Q000502:physiology*
chemical_list: D017931:DNA Primers; D012333:RNA, Messenger; D051636:X-Linked Inhibitor of Apoptosis Protein